AgPlenus Announces Discovery of a New Mode of Action for Fungicides Against Wheat Disease
14 February 2025, Rehovot: AgPlenus Ltd., a global leader in designing and developing novel sustainable crop protection products and a subsidiary of
Read More
Evogene
Lavie Bio Advances its Bio-Fungicide LAV321, Targeting Downy Mildew, to Pre-Commercial Stage Following Successful 2024 Field Trial Results
20 November 2024, Israel: Lavie Bio Ltd., a leading ag-biologicals company and subsidiary of Evogene Ltd. (Nasdaq: EVGN, TASE: EVGN), today announced
Read More
Lavie Bio Announces Commercial Expansion of Yalos as Seed-Treatment for Soybean, Following Successful Field Trials
13 November 2024, Israel: Lavie Bio Ltd., a leading ag-biologicals company and a subsidiary of Evogene Ltd. (Nasdaq: EVGN, TASE: EVGN), today
Read More
Evogene Announces Collaboration with Google Cloud to Pioneer Generative AI Foundation Model for Novel Small Molecule Design
04 November 2024, Israel: Evogene Ltd. (NASDAQ: EVGN, TASE: EVGN), a leading computational biology company aiming to revolutionize life-science-based product discovery and development,
Read More
Casterra Announces a Key Milestone in its Operational Expansion Plan in Africa, with Completion of First Shipment of Castor Seeds Grown and Processed in Kenya
30 October 2024, Israel: Casterra Ag Ltd. (“Casterra”), an integrated castor cultivation solution company for oil production for bio-based products and biofuel,
Read More
Watershed AC, Evogene and Ben-Gurion University Receive Approval for Second Year Grant to Continue the Collaboration Focused on Improving Crustacean Traits Utilizing Gene Editing Technology
10 October 2024, Israel: Watershed AC (“Watershed”, formerly Colors Farm Ltd.) , a cutting-edge company in sustainable aquaculture and biotech and Evogene Ltd. (“Evogene”)
Read More
Lavie Bio Receives Grant from Israel Innovation Authority to Advance the Development of ‘MicroFermentor’, a Unique Technology that Can Change the Economics of Ag-Biologicals
03 October 2024, Israel: Lavie Bio Ltd., a leading ag-biologicals company and a subsidiary of Evogene Ltd. (Nasdaq: EVGN, TASE: EVGN), announced
Read More
Evogene Announces Pricing of US$5.5 Million Registered Direct Offering and Concurrent Private Placement
26 August 2024, Israel: Evogene Ltd. (“Evogene” or the “Company”) (Nasdaq: EVGN, TASE: EVGN), a leading computational biology company aiming to revolutionize
Read More
Casterra Announces the Completion of a Successful Castor Seed Growing and Harvesting Season in Brazil
01 August 2024, Israel: Casterra Ag Ltd., a subsidiary of Evogene Ltd. (Nasdaq: EVGN, TASE: EVGN), and a provider of an integrated
Read More
ICL and Lavie Bio Leverage Artificial Intelligence to Make Significant Advancement in Development of Yield Increasing Bio-Stimulants
18 July 2024, Israel: ICL (NYSE: ICL) (TASE: ICL), a leading global specialty minerals company, and Lavie Bio Ltd., a leading ag-biologicals
Read More